No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.

The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

The FDA and CDC, divisions of the HHS, are expected to lose as much as 1 in 5 employees in new cuts overseen by RFK Jr.

Multiple unvaccinated children showed signs of vitamin A toxicity after RFK Jr promoted using it to treat and prevent measles infection.

Utah's ban on fluoridation could negatively impact oral health, especially among children and low-income communities.

Brian King, the FDA's top tobacco regulator, saw lower rates of teen vaping nationwide before being removed from his position this week.